摘要 |
FIELD: chemistry.SUBSTANCE: described fused protein contains at least two amino acid sequences. The first amino acid sequence, having 90% sequence identity with an amino acid sequence represented in SEQ ID NO:2, is fused with a second amino acid sequence, having at least 90% sequence identity with an amino acid sequence represented in SEQ ID NO:4.EFFECT: invention provides immunity against various clinically vital strains of group B streptococci.9 cl, 5 dwg, 8 ex |